TrialJournal of Crohn's & colitis2024

Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.

Séverine Vermeire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.